Who makes [18F]PT2385?

[18F]PT2385 is developed by Orhan Kemal Oz.

Last reviewed 2026-04-20 · How we verify

[18F]PT2385

Orhan Kemal Oz · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	[18F]PT2385
Sponsor	Orhan Kemal Oz
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[18F]PT2385 CI brief — competitive landscape report
[18F]PT2385 updates RSS · CI watch RSS
Orhan Kemal Oz portfolio CI